Dual Cytokine Blocker Holds Psoriasis at Two-Year Mark
Bioengineer.org this week reported a dual cytokine blocker held psoriasis in remission for two full years. The molecule hits two inflammatory pathways in parallel, and patients stayed controlled acro…